Status
Conditions
Treatments
About
The purpose of this study is to describe the use of teclistamab/talquetamab in the treatment of patients with RRMM outside of clinical trials.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
600 participants in 3 patient groups
Loading...
Central trial contact
Study Contact
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal